Wide Ranks

BHC

Bausch Health Companies Inc.

8.12

Top Statistics
Market Cap 2 B Forward PE 1.90 Revenue Growth 12.20 %
Current Ratio 1.19 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -1.88 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 8.05 Enterprise / Revenue 2.61 Price To Sales Trailing12 Months 0.3152
Profitability
Profit Margins -1.88 % Operating Margins 21.67 %
Balance Sheet
Total Cash 719 M Total Cash Per Share 1.96 Total Debt 21 B
Total Debt To Equity Current Ratio 1.19 Book Value Per Share -3.19
All Measures
Short Ratio 470.00 % Message Board Id finmb_345779 Shares Short Prior Month 12 M
City Laval Uuid 9e7b84f3-aa99-3efa-83c3-c9d91980d6fa Previous Close 7.89
First Trade Date Epoch Utc 764 M Book Value -3.19 Beta 0.7450
Total Debt 21 B Volume 928905 Last Split Date 971 M
Fifty Two Week Low 3.96 Total Cash Per Share 1.96 Total Revenue 9 B
Shares Short Previous Month Date 1 B Target Median Price 9.00 Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins 21.67 % Target Mean Price 8.57
Net Income To Common -178000000 Ask 8.12 Short Percent Of Float 0.0275
Implied Shares Outstanding 369 M Last Fiscal Year End 1 B Trailing Peg Ratio None
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 719 M
Next Fiscal Year End 1 B Revenue Per Share 25.79 Held Percent Insiders 0.1108
Ebitda Margins 32.39 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 7.89 Target Low Price 3.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 8.41 Open 7.90
Free Cashflow 1 B State QC Dividend Yield 0.00 %
Return On Assets 0.0415 Time Zone Short Name EST Trailing Eps -0.4800
Day Low 7.86 Address1 2150 St. ElzEar Boulevard West Shares Outstanding 367 M
Price Hint 2 Target High Price 12.00 Website https://www.bauschhealth.com
52 Week Change 0.1373 Average Volume 2 M Forward Eps 4.41
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 62.40 %
Last Split Factor 2:1 Regular Market Day High 8.14 Is_sp_500 False
Profit Margins -1.88 % Fifty Two Week High 11.46 Day High 8.14
Shares Short 9 M Regular Market Open 7.90 Industry Key drug-manufacturers-specialty-generic
Bid 8.04 Earnings Growth 0.00 % Enterprise To Revenue 2.61
Revenue Growth 12.20 % Shares Percent Shares Out 0.0254 Operating Cashflow 1 B
Five Year Avg Dividend Yield 652.00 % Currency USD Market Cap 2 B
Time Zone Full Name America/New_York Is_nasdaq_100 False Zip H7L 4A8
Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic Ex Dividend Date 1 B
Regular Market Day Low 7.86 Held Percent Institutions 0.7141 Long Name Bausch Health Companies Inc.
Current Price 8.12 Enterprise To Ebitda 8.05 Financial Currency USD
Current Ratio 1.19 Gross Margins 70.87 % Industry Disp Drug Manufacturers - Specialty & Generic
Number Of Analyst Opinions 7 Country Canada Float Shares 276 M
Two Hundred Day Average 7.71 Enterprise Value 24 B Price To Sales Trailing12 Months 0.3152
Forward PE 1.90 Regular Market Volume 928905 Last Dividend Date 1 B
Ebitda 3 B Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally.

It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

The Salix segment provides gastroenterology products in the United States.

The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally.

The Solta Medical segment engages in the sale of aesthetic medical devices.

The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States.

The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products.

The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018.

Bausch Health Companies Inc. is headquartered in Laval, Canada.